HOME PRODUCTS COMPANY CONTACT FAQ

Research Dictionary Pharma

Sign Up FREE or Login

1,1'- bis- (4- sulfobutyl)indotricarbocyanine- 5,5'- dicarboxylic acid diglucamide

Also Known As:

1,1'-bis-(4-sulfobutyl)indotricarbocyanine-5,5'-dicarboxylic acid diglucamide monosodium salt; SIDAG

Networked: 3 relevant articles (0 outcomes, 0 trials/studies)

Bio-Agent Context: Research Results

Organic Chemicals: 133
- Hydrocarbons: 1713
  - Acyclic Hydrocarbons
    - Alkynes: 217
      - Carbocyanines: 74
        1,1'-bis-(4-sulfobutyl)indotricarbocyanine-5,5'-dicarboxylic acid diglucamide: 3

Experts

1.	Licha, Kai: 3 articles (06/2011 - 01/2006)
2.	Ebert, Bernd: 2 articles (06/2011 - 01/2006)
3.	Schirner, Michael: 2 articles (01/2008 - 01/2006)
4.	Riefke, Björn: 1 article (06/2011)
5.	Sukowski, Uwe: 1 article (06/2011)
6.	Bremer, Christoph: 1 article (01/2008)
7.	Hauff, Peter: 1 article (01/2008)
8.	Heindel, Walter: 1 article (01/2008)
9.	Matuszewski, Lars: 1 article (01/2008)
10.	Müller, Silke: 1 article (01/2008)

Related Diseases

1.	Neoplasms (Cancer) 06/01/2011 - "Our findings demonstrate that SIDAG is a high potential contrast agent for optical imaging, which could increase the sensitivity for detection of inflamed regions and tumors." 01/01/2008 - "Differentiation of angiogenic burden in human cancer xenografts using a perfusion-type optical contrast agent (SIDAG)." 06/01/2011 - "N-Nitrosomethylurea (NMU)-induced rat breast carcinomas are clearly demarcated, both immediately and 24 h after intravenous administration of SIDAG, whereas ICG shows a weak tumor contrast under the same conditions. "
2.	Breast Neoplasms (Breast Cancer) 06/01/2011 - "N-Nitrosomethylurea (NMU)-induced rat breast carcinomas are clearly demarcated, both immediately and 24 h after intravenous administration of SIDAG, whereas ICG shows a weak tumor contrast under the same conditions. "
3.	Experimental Arthritis 01/01/2006 - "NIR fluorescence imaging based on the pharmacokinetic behavior of ICG or SIDAG is a promising approach to detect inflammatory joint changes of experimental arthritis. "

Related Drugs and Biologics

1.	Contrast Media
2.	Methylnitrosourea (N-Methyl-N-nitrosourea)

Related Therapies and Procedures

1.	Intravenous Administration